¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"vaccination, polio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® vaccination ÇÑ±Û ¿¹¹æÁ¢Á¾
¼³¸í   
  1.ÀÎÀ§ÀûÀ¸·Î ´Éµ¿¸é¿ªÀ» ¼º¸³½ÃÄѼ­ °¨¿°¿¡ ´ëÇÑ ÀúÇ×·ÂÀ» ³ôÀ̱â À§ÇÏ¿© ¾àµ¶È­º´¿øÃ¼(»ý¹é½Å) ¶Ç´Â »ç±Õ, ºÒȰ¼º È­¹é½Å µîÀ» Á¢Á¾Çϴ °ÍÀ» ¸»ÇÑ´Ù. ´çÃÊ Á¾µÎ´Â Á¨³Ê(Jenner)¿¡ ÀÇÇØ¼­ ¹ß°ßµÈ ¸¶¸¶ ¿¹¹æ¹ý¿¡ °üÇÑ Á¢Á¾À» ÀǹÌÇßÀ¸³ª ÇöÀç¿¡´Â ³Î¸® °¨¿°ÁõÀ̳ª Àü¿°º´ÀÇ º´¿ø±Õ ±× ÀÚü°¡ ÀϺθ¦ Á¢Á¾Çؼ­ ºñ°¨¿°ÀÚ¸¦ ¸é¿ªÇϴ °ÍÀ» ÀǹÌÇÑ´Ù. ¿¹¹æÁ¢Á¾À¸·Î Ç¥ÁØÈ­µÇ¾úÀ¸¸ç, Ç׿øÀ¸·Î¼­ ¹é½ÅÀÌ »ç¿ëµÈ´Ù. ¿¹¹æÁ¢Á¾À¸·Î °¨¿°ÀÌ ¾ïÁ¦µÇÁö¸¸ ÇǺο¡ ³ªÅ¸³ª´Â ÀÌ»óÀ̳ª µÎµå·¯±â¸ð¾ç È«¹Ý µîÀÇ ÇǺιßÁøÀ̳ª ³ú¿° µîÀÇ ºÎÀÛ¿ëÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¹Ç·Î ÁÖÀǸ¦ ¿äÇÑ´Ù.
  
  2.¿¹¹æÁ¢Á¾¿¡ ¾²À̴ Ç׿ø¿¡´Â Å©°Ô ³ª´©¾î ¼¼±Õ¼º Ç׿ø°ú ¹ÙÀÌ·¯½º¼º Ç׿øÀÌ Àִµ¥, ¼¼±Õ¼º Ç׿ø¿¡´Â »ç¸êµÈ Àüü ¼¼±Õ(¹éÀÏÇØ ¹é½Å µî), º´¿øÃ¼°¡ Ã¼¿Ü·Î ¹èÃâÇϴ µ¶¼Ò¸¦ ¸êµ¶ÇÑ º¯¼ºµ¶¼Ò(Åå¼ÒÀ̵å)(µðÇÁÅ׸®¾Æ-ÆÄ»ódz µî), µ¶·ÂÀ» ¾àÈ­½ÃŲ »ý¼¼±Õü(BCG µî)µîÀÌ ÀÖ°í, ¹ÙÀÌ·¯½º¼º Ç׿ø¿¡´Â »ý¾àµ¶È­ÇÑ °Í(¼Ò¾Æ¸¶ºñ)°ú »ç¸êµÈ ¹é½Å(ÀÎÇ÷翣ÀÚ) µîÀÌ Æ÷ÇԵȴÙ. Çѱ¹¿¡¼­´Â Àü¿°º´ ¿¹¹æ¹ý¿¡ µÎâ-µðÇÁÅ׸®¾Æ-¹éÀÏÇØ-ÀåÆ¼Çª½º-ÄÝ·¹¶ó-ÆÄ»ódz-°áÇÙ µî Àϰö °³ Áúº´¿¡ °üÇÏ¿© Á¤±â ¿¹¹æÁ¢Á¾À» ½ÃÇàÇϵµ·Ï µÇ¾î ÀÖ´Ù. ¶Ç ´ëÇѼҾưúÇÐȸ¿¡¼­´Â BCG-¼Ò¾Æ¸¶ºñ-µðÇÁÅ׸®¾Æ-¹éÀÏÇØ-ÆÄ»ódz-È«¿ª-À¯Ç༺±Í¹Ø»ù¿°(º¼°Å¸®)-dzÁø-ÀϺ»³ú¿° µî ¾ÆÈ© °³ ¿¹¹æÁ¢Á¾À» Á¤Çϰí ÀÖ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polio
    ȸ»öÁúô¼ö¿°
  • BCG vaccination
    BCGÁ¢Á¾
  • vaccination
    ¿¹¹æÁ¢Á¾
  • vaccination reaction
    ¹é½Å¹ÝÀÀ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vaccination
    ¿¹¹æÁ¢Á¾
  • BCG vaccination
    ºñ¾¾ÁöÁ¢Á¾
  • pneumococcal vaccination
    Æó·Å¾Ë±Õ¿¹¹æÁ¢Á¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polio
    (¢¡poliomyelitis) ȸ»öÁúô¼ö¿°
  • BCG vaccination
    ºñ¾¾ÁöÁ¢Á¾
  • regional vaccination
    Áö¿ª¿¹¹æÁÖ»ç
  • vaccination reaction
    ¹é½Å¹ÝÀÀ
  • vaccination
    ¿¹¹æÁ¢Á¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • BCG=£¾ Bacillus Calmette Guerin vaccination
    BCG Á¢Á¾.
  • infantile paralysis =polio
    ¼Ò¾Æ¸¶ºñ(á³ä®Ø«Ýö), ¿µ¾Æ¼º ¸¶ºñ.
  • poliomyelitis =polio
    ¼Ò¾Æ¸¶ºñ, Æú¸®¿À, ȸ»öô¼ö¿°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bulbar polio
    ¿¬¼ö¼º Æú¸®¿À.
  • infantile paralysis =polio
    ¼Ò¾Æ¸¶ºñ(á³ä®Ø«Ýö), ¿µ¾Æ¼º ¸¶ºñ.
  • mouse polio
    ¸¶¿ì½ºÆú¸®¿À.
  • nonparalytic polio
    ºñ¸¶ºñ¼º Æú¸®¿À, ºñ¸¶ºñ¼º ȸ¹é¼ö¿°.
  • paralytic polio
    ¸¶ºñ¼º Æú¸®¿À.
  • poliomyelitis =polio
    ¼Ò¾Æ¸¶ºñ, Æú¸®¿À, ȸ»öô¼ö¿°.
  • spinal paralytic polio
    ô¼öÇü ¸¶ºñ¼º Æú¸®¿À(ô±âÐû¡Ø«Ýöàõ¡­ )
  • compulsory vaccination
    °­Á¦<¹ýÁ¤>Á¢Á¾(˧̡<ËÑËø>ËøÌ¡), °­Á¦Á¾µÎ¹ý.
  • intradermal vaccination
    Çdz»¹é½ÅÁÖ»ç, Çdz»¿¹¹æÁ¢Á¾.
  • intrauterine vaccination
    Àڱó»Á¾µÎ(¡­ðþÔã), Àڱó»Á¢Á¾(¡­ïÈðú).
  • mass vaccination
    Áý´Ü(¿¹¹æ)Á¢Á¾(ó¢Ó¥çãÛÁïÈðú).
  • mass vaccination
    Áý´Ü(¿¹¹æ)Á¢Á¾(̤ËÀËçËÑËøÌ¡).
  • regional vaccination.
    °¨¿°¹®¹é½ÅÁÖ»ç(ÊïæøÚ¦¡­ñ¼ÞÒ).
  • smallpox vaccination
    µÎâ (Ôãóê) ¿¹¹æÁ¢Á¾
  • smallpox vaccination
    Á¾µÎ(ðúÔã).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vaccination
    ¿¹¹æÁ¢Á¾, Á¾µÎ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
vacc vaccination
VS vaccination scar; vaccine serotype; vagal stimulation; vasospasm; venesection; ventricular septum; v...
OPV Oral Polio-Vaccine; °æ±¸¿ë ¼Ò¾Æ¸¶ºñ ¹é½Å
TOPV Trivalent Oral Polio(myelitis) Vaccine; °æ±¸¿ë ¼Ò¾Æ¸¶ºñ È¥ÇÕ¹é½Å
eIPV enhanced inactivated polio vaccine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
PV post vaccination
IPV Inactivated Polio-Vaccine
OPV Oral Polio Vaccine
PPS Post-polio syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • paralytic polio
    ¸¶ºñ¼º Æú¸®¿À
  • polio vaccine
    ¼Ò¾Æ ¸¶ºñ ¹é½Å
    ¼Ò¾Æ ¸¶ºñÀÇ ¿¹¹æÀ» À§ÇÏ¿© ¾²ÀÌ´Â ¸é¿ª¿ø.
  • primary vaccination :

    primary's area

    Á¦1¿µ¿ª
    ¿îµ¿°ú °¨°¢ºÎ¸¦ Æ÷ÇÔÇÏ´Â ´ë³ú ÇÇÁú ¿µ¿ª.
  • small pox vaccination
    õ¿¬µÎ ¿¹¹æ Á¢Á¾
    Jenner¿¡ ÀÇÇØ °³¹ßµÈ õ¿¬µÎ ¹é½ÅÀÇ µµ¿òÀ¸·Î 1977³â 10¿ù ¼Ò¸»¸®¾Æ¿¡¼­ÀÇ È¯ÀÚ ¹ß»ý°ú 1978³â ½ÇÇè½Ç¿¡¼­ ¹ß»ýÇÑ µÎ°ÇÀ» ³¡À¸·Î Áö±¸»ó¿¡¼­ õ¿¬µÎ´Â ¿ÏÀüÈ÷ »ç¶óÁö°Ô µÇ¾ú´Ù.
  • smallpox vaccination
    µÎâ ¿¹¹æ Á¢Á¾, Á¾µÎ
  • vaccination accident
    ¿¹¹æÁ¢Á¾ »ç°í
    ¿¹¹æÁ¢Á¾À» ¹Þ¾Æ¼­ »ý±ä »ç°í.
  • vaccination rash
    Á¾µÎÁø
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
vaccination, polio The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
polio vaccination <virology> The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine).
Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth.
Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age.
Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(21 Jun 1999)
polio <virology> An epidemic viral infection which attacks the motor neurons of the anterior horns in the brainstem and spinal cord.
Vaccination against this disease is recommended.
(27 Sep 1997)
polio immunization <virology> The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine).
Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth.
Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age.
Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(21 Jun 1999)
immunization, polio The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(12 Dec 1998)
inactivated polio vaccine <pharmacology, virology> An inactivated vaccination, administered by injection to children for protection against the polio virus. Typically given at 2, 4 and 15 months. A final vaccine is recommended at 4-6 years.
(27 Sep 1997)
oral polio vaccine <drug> A live vaccination, administered orally to children for protection against the polio virus. Typically given at 2, 4 and 15 months. A final oral vaccine is recommended at 4-6 years.
(27 Sep 1997)
French polio Colloquialism for Guillain-Barre syndrome.
(05 Mar 2000)
vaccination <procedure> The introduction of vaccine into the body for the purpose of inducing immunity. Coined originally to apply to the injection of smallpox vaccine, the term has come to mean any immunising procedure in which vaccine is injected.
Origin: L. Vacca = cow
(18 Nov 1997)
vaccination, anthrax A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the usa was first developed in the 1950s and approved by the food and drug administration for general use in 1970. It is produced by the michigan biologic products institute of michigan's department of health and is given routinely to veterinarians and others working with livestock. In december, 1997 it was announced that all us military would receive the vaccine, as do the military in the uk and russia, the reason being concern that anthrax might be used in biologic warfare.
(12 Dec 1998)
vaccination, chickenpox This vaccine prevents the common disease known as chickenpox (varicella zoster). While chickenpox is often considered a trivial illness, it can cause significant lost time on the job and in school and have serious complications including ear infections, pneumonia, and infection of the rash with bacteria, inflammation of the brain (encephalitis) leading to difficulty with balance and coordination (cerebellar ataxia), damaged nerves (palsies), and reye's syndrome, a potentially fatal complication. The vaccination requires only one shot given at about a year of age. If an older person has not had chickenpox, the shot may be given at any time. There have been few significant reactions to the chickenpox vaccine. All children, except those with a compromised immune system, should have the vaccination.
(12 Dec 1998)
vaccination, children's In the United States, it is recommended that all children receive vaccination against: - hepatitis b - diphtheria, tetanus, pertussis - haemophilus influenzae type b (hib), poliovirus, measles, mumps, rubella, varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination.
(12 Dec 1998)
vaccination, dpt DPT immunization protects from diphtheria, pertussis (whooping cough), and tetanus and is given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. However, there are still unvaccinated individuals capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil. See also vaccination, dtap.
(12 Dec 1998)
vaccination, dt DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease
(12 Dec 1998)
vaccination, dtap Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age.
(12 Dec 1998)
vaccination, german measles See Vaccination, MMR.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polio
    ¼Ò¾Æ¸¶ºñÁõ
  • polio
    ¼Ò¾Æ¸¶ºñ
  • vaccination
    ¿ÎÂð ÁÖ»ç
  • ring vaccination
    Àü¿ø Á¢Á¾(Àü¿°º´ ȯÀÚÀÇ °ü°èÀÚ Àü¿ø¿¡ ´ëÇÑ)
  • vaccination
    ¹é½Å(¿¹¹æ)Á¢Á¾;Á¾µÎ;Á¾µÎ ÀÚ±¹
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á